[Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
[Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
S. Morabito,I. Guzzo,4 Authors,A. Pierucci
2006
Giornale Italiano di Nefrologia · 4 Citations
TLDR
The molecular weight cut-offs of high-flux membrane are much higher than the molecular weight of most drugs, therefore, molecular size will not be a limitation for the removal of the unbound fraction of the drugs most commonly used in the critically ill undergoing continuous renal replacement therapy (CRRT).
